Your browser doesn't support javascript.
loading
Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis.
Fan, Qinghong; Liu, Yujuan; Rao, Jiaoyu; Zhang, Zhe; Xiao, Wei; Zhu, Tao; Chai, Xiaomeng; Ye, Kaihe; Ning, Na; Yin, Zhen; Chai, Yushuang; Xu, Yimin; Lan, Ruirui; Verkhratsky, A; Nie, Hong.
Afiliación
  • Fan Q; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Liu Y; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Rao J; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Zhang Z; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Xiao W; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Zhu T; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Chai X; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Ye K; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
  • Ning N; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Yin Z; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Chai Y; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Xu Y; Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, Guangzhou, China.
  • Lan R; International Department, The Affiliated High School of SCNU, Guangzhou, China.
  • Verkhratsky A; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Nie H; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.
Front Pharmacol ; 10: 1584, 2019.
Article en En | MEDLINE | ID: mdl-32082145

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: China